IEMGX
Price
$9.93
Change
-$0.07 (-0.70%)
Updated
Nov 14 closing price
RNWEX
Price
$80.37
Change
-$0.38 (-0.47%)
Updated
Nov 14 closing price
Ad is loading...

IEMGX vs RNWEX

Header iconIEMGX vs RNWEX Comparison
Open Charts IEMGX vs RNWEXBanner chart's image
Voya Multi-Manager Emerging Markets Eq I
Price$9.93
Change-$0.07 (-0.70%)
VolumeN/A
CapitalizationN/A
American Funds New World R4
Price$80.37
Change-$0.38 (-0.47%)
VolumeN/A
CapitalizationN/A
IEMGX vs RNWEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IEMGX vs. RNWEX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IEMGX is a Sell and RNWEX is a Buy.

FUNDAMENTALS
Fundamentals
RNWEX has more cash in the bank: 61.8B vs. IEMGX (199M). IEMGX pays higher dividends than RNWEX: IEMGX (1.92) vs RNWEX (1.24). IEMGX was incepted earlier than RNWEX: IEMGX (13 years) vs RNWEX (22 years). IEMGX is a more actively managed with annual turnover of: 85.00 vs. RNWEX (32.00). RNWEX has a lower initial minimum investment than IEMGX: RNWEX (250) vs IEMGX (250000). RNWEX annual gain was more profitable for investors over the last year : 13.19 vs. IEMGX (10.52). RNWEX return over 5 years is better than : 17.93 vs. IEMGX (-10.91).
IEMGXRNWEXIEMGX / RNWEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years22 years-
Gain YTD3.4138.38941%
Front LoadN/AN/A-
Min. Initial Investment250000250100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets199M61.8B0%
Annual Yield % from dividends1.921.24154%
Returns for 1 year10.5213.1980%
Returns for 3 years-26.06-13.68191%
Returns for 5 years-10.9117.93-61%
Returns for 10 years2.9841.347%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DORM137.85-0.15
-0.11%
Dorman Products
TEVA16.94-0.17
-0.99%
Teva Pharmaceutical Industries Limited
CAPR16.91-1.19
-6.57%
Capricor Therapeutics
GEVO1.42-0.22
-13.41%
Gevo
OLB2.01-0.40
-16.46%
OLB Group Inc. (The)